SOCIEDADE BRASILEIRA DE ORTOPEDIA E TRAUMATOLOGIA
w w w . r b o . o r g . b r
Original
article
Vitamin
D
status
and
its
relationship
with
bone
mineral
density
in
a
healthy
Iranian
population
Patricia
Khashayar
a,b,∗,
Hamid
Reza
Aghaei
Meybodi
a,
Mohsen
Rezai
Hemami
c,
Abbasali
Keshtkar
d,e,
Hans
Peter
Dimai
f,
Bagher
Larijani
caOsteoporosisResearchCenter,EndocrinologyandMetabolismClinicalSciencesInstitute,TehranUniversityofMedicalSciences,
Tehran,Iran
bCenterforMicrosystemsTechnology(CMST),GhentUniversity,Ghent,Belgium
cEndocrinologyandMetabolismResearchCenter,EndocrinologyandMetabolismClinicalSciencesInstitute,
TehranUniversityofMedicalSciences,Tehran,Iran
dDepartmentofHealth,TheMinistryofHealthandMedicalEducation(MOHME),Tehran,Iran
eDepartmentofNutrition,TheMinistryofHealthandMedicalEducation(MOHME),Tehran,Iran
fDepartmentofInternalMedicine,DivisionofEndocrinologyandMetabolism,MedicalUniversityofGraz,Graz,Austria
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received26August2015 Accepted9September2015 Availableonline2February2016
Keywords:
Bonemineraldensity Osteoporosis Biologicalmarkers
VitaminD
Phosphorus Calcium
a
b
s
t
r
a
c
t
Objectives:Consideringthecontroversialresultsregardingtherelationshipbetweenvitamin Dlevelsandbonemineraldensityindifferentpopulations,thepresentstudywasdesigned toevaluatethiscorrelationinahealthyIranianpopulation.
Methods:Usingarandomclustersampleofapparentlyhealthymenandwomen,this multi-centercross-sectionalstudywascarriedoutamong4450individualslivinginurbanareasof fivemajorcitiesinIran.Bonemineraldensity(BMD)valuesatdifferentsiteswereanalyzed alongwiththeserumlevelsof25(OH)DandPTH.Analysisofvariance(ANOVA)wasusedto estimatethemaineffects,throughcomparingthemeanvaluesofthesemarkersbasedon thebonemineraldensitystatusofthestudygroupineachsex.
Results:25(OH)DlevelswereinverselycorrelatedwithBMDvaluesattotalhip(r=−0.062in menandr=−0.057inwomen)andspine(r=−0.076inmenandr=−0.107inwomen).After adjustingthedataforage,theinversecorrelationwasnolongerstatisticallysignificant. Conclusion:Serum25(OH)Dlevelsareinverselycorrelatedwithbonemassvaluesinboth sexes.
©2015SociedadeBrasileiradeOrtopediaeTraumatologia.PublishedbyElsevierEditora Ltda.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Correlac¸ão
entre
os
níveis
de
vitamina
D
e
densidade
mineral
óssea
em
uma
populac¸ão
iraniana
saudável
Palavraschave:
Densidademineralóssea Osteoporose
r
e
s
u
m
o
Objetivos:Considerandoosresultadoscontroversossobrearelac¸ãoentreníveisdevitamina Dedensidademineralósseaemdiferentespopulac¸ões,opresenteestudofoidesenhado paraavaliarestacorrelac¸ãoemumapopulac¸ãoiranianasaudável.
∗ Correspondingauthor.
E-mail:patricia.kh@gmail.com(P.Khashayar).
http://dx.doi.org/10.1016/j.rboe.2015.09.011
Biomarcadores VitaminaD Fósforo Cálcio
Métodos: Usandoumaamostraaleatóriadehomensemulheresaparentementesaudáveis, esteestudotransversalmulticêntricoconsiderou4450indivíduosquevivememnaregião urbanade cincograndescidadesnoIrã.Osvalores dadensidademineralóssea(DMO) foramanalisadosemconjuntocomosníveisséricosde25(OH)DePTH.Análisedavariac¸ão (ANOVA)foiutilizadaparaestimarosprincipaisefeitosatravésdacomparac¸ãoentreos val-oresmédiosdestesmarcadoreseacondic¸ãodadensidademineralósseadecadagênero nestaamostradeestudo.
Resultados:Níveisde25(OH)DforaminversamenteproporcionaisaosvaloresdeDMOanível doquadril(r=-0.062emhomenser=-0.057emmulheres)ecolunavertebral(r=-0.076em homenser=-0.107emmulheres).Apósajustedosdadosparaidade,acorrelac¸ãonegativa nãofoimaisestatisticamentesignificante.
Conclusão: Níveisséricosde25(OH)Dsãoinversamentecorrelacionadoscomosvaloresde massaósseaemambososgêneros.
©2015SociedadeBrasileiradeOrtopediaeTraumatologia.PublicadoporElsevier EditoraLtda.Este ´eumartigoOpenAccesssobumalicenc¸aCCBY-NC-ND(http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Osteoporosisisasystemicdiseasecharacterizedbylowbone
mass and microarchitectural deterioration of bone tissue,
resultinginanincreasedriskoffracture;ifidentifiedearlyin itscourse,however,manyofthefracturescanbeprevented.1
Apartfrommodifiablelifestylefactors,bonemineral den-sity(BMD)isinfluencedbyseveralgenetic,environmental,and hormonalfactors.2,3Whiletheinfluenceofbiochemical
mark-ersonthefractureriskhasbeenwelldocumentedinprevious
studies,theassociationbetween serum25(OH)D levelsand
BMDindifferentethnicitiesresidingindifferentgeographic areasremainscontroversial.Manyofthemhavereportedno
directrelationshipbetweenserum 25(OH)Dlevelsand BMD
wasobserved.4
Thepresentstudythereforewasdesignedtoevaluatethe relationshipbetweenvitaminDstatus,bonemineraldensity andPTHinahealthyIranianpopulation.
Materials
and
methods
Subjectselection
Thisstudyispartofacomprehensivesurvey(IMOS)assessing
the prevalence of osteoporosis and related factors among
healthyadults(agerange:20–70Years),representativesample ofIranianpopulationlivinginurbanareas,intheurbanareas offivemajorcitiesofIran(Tehran,Tabriz,Mashhad,Shiraz andBooshehr)inlatewinter2001(February–March).
Details on the survey design and methods have been
reportedpreviously.5Briefly,theIMOSusedarandomcluster
samplingdesigntodrawfiveprovinciallyrepresentative,
inde-pendent samplesof healthy adults excluding those taking
medicationsthatcouldmodifybonemetabolism,thosewith
hepaticorrenaldisorders,metabolicbonedisease, hypercor-tisolism, malabsorption,sterility, oligomenorrhea, diabetes,
malignancy,and immobility formore than 1weekas well
asthepregnant andlactating women.TheResearchEthics
CommitteeoftheEndocrineandMetabolismResearchCenter
(EMRC) approved the protocol of this study. An informed
consentwasobtainedfromthesubjectsbeforetheyentered thestudy.
All subjects underwent adetailed medicalexamination,
measurementofbonemineraldensityatdifferentsites,and
certain biochemical testing. Apart from demographic data,
thesubjectswereaskedabouttheirmenopausalstatusand
theyearspassedsincetheirmenopause.Menopause,inthis study,wasdefinedaspreviousnaturalorsurgicalcessationof
menstruationformorethan12months.
Biochemicaltests
Afastingblood sample(10cm3 ofvenousblood) wastaken
from all participants attheir residence place. Sample
cen-trifuge and serum extraction were done in the field. The
sampleswerethenfrozenandsenttotheEMRClaboratory
forfurtheranalysis.
Serum Caand Plevels were analyzed bya calorimetric
methodusingChem.EnzymeLabKit;Iran.Thenormal
labo-ratoryrangeforserumCawas8.6–10.8mg/dlandforserum
P was 2.3 to 5mg/dl. Serum levels of vitamin D (25 (OH)
D)andPTHweremeasuredwithRIA(Radio-Immuno-Assay)
method (IDS LtdKit; UK) and IRMA (Immuno-Radiometric)
method (Diasorin Kit; USA), respectively. Normal range for
serum25(OH)DandPTHwere23–113ng/mland13–54pg/ml,
correspondingly.Theinter-andintra-assayvariationsforthe markerswere8%/6.8%and8.9%/6.1%,respectively.
Basedon25(OH)Dvalues,subjectswereclassifiedasthose suffering from vitamin D deficiency (≤20ng/ml), – insuffi-ciency(milddeficiency)(20–30ng/ml)and–sufficiency(higher
than30ng/ml).Thecompletemethodusedtodeterminethe
25(OH)Dlevelsforclassifyingtheparticipantsisdescribedin ourpreviousstudies.6,7
Bonemineraldensity
Ineachcity,patientsunderwentanL1–L4anteroposterior
lum-bar spine,hip andits sub-regionsDXA studywitha Lunar
DPXMDdensitometer(Lunar7164,GE,Madison,WI)equipped
Z-scores.Qualitycontrolprocedureswerecarriedoutin
accor-dance with the manufacturer’s recommendations. In each
city,theinstrumentvariationwasdeterminedregularlybya weeklycalibrationprocedureusingaphantomsuppliedbythe
manufacturer(thephantomequilibriumwassentfromone
citytoanotheraftereach testing).Theinterdevicevariance wascheckedseveraltimesduringthestudyperiod.Therewas anirrelevantsmalldifferencebetweenthereportedmeasures whichwasnegligible.PrecisionerrorforBMDmeasurements was1–1.5%inthelumbarand2–3%inthefemoralregions.
BasedonWorldHealthOrganizationStudyGroup
recom-mendation,BMDvalueswereclassifiedasnormal,osteopenic andosteoporotic.8Since,thereisnowidelyaccepteddefinition
ofosteoporosisinmales,theWHOcriteriafortesting osteo-porosisinthefemalepopulationwassimilarlyusedforthis group.
Statisticalanalysis
DatawereenteredtoMicrosoftAccessDatabank.Inviewofthe factthatadifferentinstrumentwasusedtoassesstheBMD insubjectswhowererecruitedinBooshehr;datagatheredin thiscitywasassumedtobemissing.Allstatisticalanalyses
wereperformedwithSPSS13.0forWindows(SPSS,Chicago,
IL)basedonapair-wiseapproach,andPvalueslowerthan0.05 wereconsideredstatisticallysignificant.
All analyses were conducted separately for each
gen-der,and then forthe group overall.Means±SD were used
to express standard descriptive statistics.Categorical
vari-ables were expressed as percentages and compared using
Chi-square.Differencesamongmeans wereinvestigatedby
analysisofvariance(ANOVA)withposthoctest.Thetwo-sided
Student’st-testwas used to compare the mean
biochemi-calvaluesindifferentgroups.Theassociationbetweenthe
outcome variable(BMD) and thebiochemical variableswas
examinedbybivariateanalysisandthenbyadjustedstepwise multipleregressionanalyses.
Results
Atotalof4450individualswiththemeanageof42.6±13.9
years were studied; from among them 1900 (42.7%) were
male. Overally some 246 (6.5%) of the total studied
sub-jects(4.8% ofmales and7.7%offemales) werereported to haveosteoporosis.Therewasasignificantdifferencebetween thefrequenciesofosteoporosisamongthetwogenders(P -value<0.001).Osteopenia,onthe otherhand,wasreported among848(58.6%)ofthestudiedfemalesandsome600(41.4%) ofthestudiedmen.
Serumlevels of25(OH)D wassignificantlyhigheramong
thosesufferingfromosteoporosis(Table1).ThePearson’s cor-relationcoefficientsbetweenthestudyvariablesrevealedan inversecorrelationbetween25(OH)DlevelsandBMDvaluesat totalhip(r=−0.062inmenandr=−0.057inwomen)andspine (r=−0.076inmenandr=−0.107inwomen)(Table2).
Thecorrelation between PTH levels and BMDvalues at
allsitesfailedtoremainsignificant afteradjustingdatafor gender.Eachyearincreaseinagewasassociatedwith1.061 and1.141higherriskofdevelopingosteoporosisinmalesand
females, respectively. After adjusting the data forage, the inversecorrelationbetweenage,and25(OH)DlevelsandBMD valuesatallsiteswasnolongerstatisticallysignificant(data
notshown).
Discussion
HypovitaminosisDandosteoporosisisfrequentinindividuals livingincountrieswithabundantsunshinesuchasIran.9–12
The reasonbehind this finding, however, remains unclear.
Many believethe optimal level of25(OH)D, which leadsto
maximumsuppressionofcirculatingiPTHlevels,shouldbe
definedbasedonfunctionalratherthananepidemiological definition.13
Consideringthecorrelationbetweenserum25(OH)Dlevels and BMDvaluescontroversialresultsare found.While cer-tain studies havefailedto reportany correlationsbetween thesetwovariables,others haverevealedapositive associ-ation betweenserum25(OH)D levelsand BMDvalues.4,14–18
Aryaetal.reportedasignificantcorrelationbetweenserum
25(OH)D levels and BMDvalues atproximal femur.11 They
concludedthatsubclinical25(OH)Ddeficiencyhasanadverse effectonbonemassandthereforeislinkedwithlowBMDin thesesubjects.Villarealetal.similarlysuggestedthatwomen withlowserum25(OH)Dlevelsshouldbereferredfor osteo-porosisscreening,stressingthatlowBMDcouldbetheonly
symptominthesewomen.19
Onthecontrarywiththesestudies,thepresentresearch
demonstrated a significant but negative relation between
25(OH)DlevelsandBMDvaluesatallthestudiedsites.
Apparentdiscrepancies betweenourstudyand previous
ones can be contributed to the fact that many of these
population-basedstudieshaverecruitedsubjectswitha rel-ativelygoodhealthstatus,andthereforelowerprevalenceof severevitaminDdeficiencyandosteoporosis.14Theprobable
associationbetween25(OH)DandBMDmayalsovarybasedon
thevarioussitesusedfordensitometrymeasurementowing
todifferentcompositionoftrabecularandcorticalbone tis-sue.Moreover,samplingfromapopulation-basedstudy,and comparativelylowerprevalenceofseverevitaminDdeficiency mightincreasethegeneralizabilityofourresults.Inaddition, thehigherserum levelsof25(OH)Dinosteoporoticpatients couldbesecondarytothefactthatosteoporosisismore com-monamongtheelderlyandthisagegrouparemorefrequently treatedwithVitaminDsupplements.Consideringour exclu-sioncriteria,individualstakingsuchsupplementsshouldnot havebeen recruitedinthepresentstudy;this comeswhile manypeople,particularly,olderindividuals,havereceivedthe
supplementswithoutbeingawareoftheirname.
Themeanserum25(OH)Dconcentrationofthewholestudy
populationwas35.37±30.3ng/mlandsome67.2%ofthe stud-iedsubjectswerereportedtohavemoderatetoseverevitamin Ddeficiencyregardlessoftheirgender.Exceptfortrochanter, therewasnodifferenceinthecorrelationbetweenthese vari-ablesinthetwogenders.Itshouldbenotedthatthehigher vitaminDlevelsreportedinosteoporoticcasesinthisstudy couldbecontributedtothelowernumberofstudied
osteo-porotic casescompared tothat ofnormalcases.Moreover,
Table1–Themeanvaluesofthestudiedbiochemicalmarkersbasedonbonemineraldensitycategorization.
Bonemineraldensitycategorization(no.ofcases) Pvalue
Osteoporosis(246) Osteopenia(1448) Normal(2096)
25(OH)D(ng/ml) 42.03±34.59 35.97±26.49 33.04±23.78 <0.001
PTH(pg/ml) 28.12±16.19 28.82±16.18 28.73±17.72 0.856
Ca(mg/dl) 9.44±0.54 9.43±0.56 9.46±0.57 0.454
P(mg/dl) 3.22±0.49 3.15±0.48 3.19±0.47 0.109
Dataexpressedasmean±SD.
Table2–ThepartialcorrelationbetweenbiochemicalmarkersandBMDvaluesaftercontrollingforgender(A–maleand B–female).
25(OH)D PTH Ca P BMD(femoralneck) BMD(trochanter) BMD(totalhip)
A-Male:
PTH −0.101a
Ca 0.053b −0.032a
P 0.077a 0.088a 0.213a
BMD(femoralneck) −0.073a 0.023 0.070a 0.137a
BMD(Trochanter) 0.000 −0.008 0.044 0.074b 0.770a
BMD(totalHip) −0.062b 0.013 0.064b 0.090a 0.876a 0.934a
BMD(spine) −0.076a 0.038 0.022 0.083a 0.633a 0.616a 0.666a
B-Female:
PTH −0.175a
Ca 0.079a −0.038
P 0.075a −0.072a 0.245a
BMD(femoralneck) −0.095a −0.024 0.004 0.004
BMD(Trochanter) −0.074a −0.046 −0.037 −0.054b 0.806a
BMD(totalHip) −0.057b −0.042 −0.021 −0.034 0.889a 0.926a
BMD(spine) −0.107a −0.009 −0.030 −0.053b 0.699a 0.624a 0.689a
a Correlationissignificantatthe0.01level(2-tailed).
b Correlationissignificantatthe0.05level(2-tailed).
andelderlypopulationinIranspendsmoretimeoutdoors,it
couldbeconcludedthattheyareexposedtomoresunand
thereforehavehigher25(OH)Dlevels.
Certain studies have revealed an inverse correlation
betweenserumPTHlevelsandBMDvalues,particularlyatthe femoralneck,pointingoutthecatabolicroleofPTHon corti-calbones.15,20Thesestudieshavealsoshownthatdecreased
levelsofserumcalciumareassociatedwithdefectsin min-eralizationand consequentlylowBMD.13 Inlinewiththese
studies,Hosseinpanahetal.reportedanegativecorrelation
betweenPTHlevelsandBMDvaluesatfemoralneckinthe
absenceofsimilarcorrelationsbetweenserum25(OH)Dand
BMDofothersites.21SadatAlietal.22showedthatvitaminD
levelssignificantlyinfluenceBMDreadingamongSaudi indi-viduals,pointingoutasignificantpositivecorrelationbetween 25OHDlevelandBMDandsignificantnegativecorrelationwith parathyroidhormoneinthestudiedgroups.Thepresentstudy, onthecontrary,reportedPTHtobeinverselycorrelatedwith BMDvalues atall sites rather than spine. Thecorrelation, however,wasreportedtobesignificant onlyatthefemoral trochanter.
The present study was conducted on healthy
individ-ualsbasedontheirself-reportedhistory;apotentialbiasof undiagnosedunderlyingdiseases,therefore,isprobable. Addi-tionally, the cross-sectional nature ofthe present study is animportantlimitation ofthis study. Moreover,this study
only measured fivebiochemical markers, namely PTH and
25(OH)D,whilemorerecentstudieshavelinkedmarkerssuch asintactosteocalcin(OC)toBMDvaluesandfracturerisk.23,24
Inaddition,25(OH)Dmeasurementswereperformedinwinter, when its levelsare believed tobeatthe lowestlevel com-paredtoothermonthsoftheyear.Itshouldbenotedthatthe presentstudywasanobservationalstudyinwhichtheeffectof importantfactorssuchaspopulationdifferences(gender,age, ethnic,sex,extentofsunexposure,andvitaminDintake)was notassessed.Largeprospectivestudies,therefore,areneeded tobetterevaluatethecorrelationbetweenbiochemical mark-ersandBMDvaluesindifferentpopulations.
Conflict
of
interest
Dr.Dimaireportsreceivingpaymentsforboardmembership, consultancy, expert’s testimony, travels, meetings and lec-turesforhisworkonosteoporosis(Amgen,Daiichi-Sankyo, EliLilly,Kyphon,Medtronic,MerckSharp&Dohme,Novartis, Nycomed,Sanofi-Aventis,Servier).Hisinstitution,the Med-icalUniversity ofGraz, alsoreportsreceivinggrantsforDr.
Dimai’s work on osteoporosis (Amgen, Daiichi-Sankyo, Eli
Acknowledgement
Theauthorsofthisstudywouldliketoacknowledgethe per-sonneloftheEndocrinologyandMetabolismResearchCenter, thelaboratorystaffand allthosewho kindlycooperatedin conductingthisstudy.
r
e
f
e
r
e
n
c
e
s
1. Consensusdevelopmentconference.Diagnosis,prophylaxis andtreatmentofosteoporosis.AmJMed.1993;94(6):646–50.
2. ArdawiM,MaimanyA,BahkshT,NasratH,MilaatW, Al-RaddadiR.Bonemineraldensityofthespineandfemurin healthySaudis.OsteoporosInt.2005;16(1):43–55.
3. KeramatA,PatwardhanB,LarijaniB,ChopraA,MithalA, ChakravartyD,etal.Theassessmentofosteoporosisrisk factorsinIranianwomencomparedwithIndianwomen.BMC MusculoskeletDisord.2008;27(9):28.
4. ChandranM,HoeckHC,WongHC,ZhangRF,DimaiHP. VitaminDstatusanditsrelationshipwithbonemineral densityandparathyroidhormoneinSouth-EastAsianadults withlowbonedensity.EndocrPract.2010;17(2):226–34.
5. AghaeiMeybodiH,HeshmatR,MaasoumiZ,SoltaniA, Hossein-NezhadA,KeshtkarA,etal.Iranianosteoporosis researchnetwork:background,missionanditsrolein osteoporosismanagement.IranianJPublHealth.2008;A supplementaryissueonOsteoporosisandBone Turnover(1):1–6.
6. HashemipourS,LarijaniB,AdibiH,SedaghatM,PajouhiM, Bastan-HaghM,etal.Thestatusofbiochemicalparameters invaryingdegreesofvitaminDdeficiency.JBoneMiner Metab.2006;24(3):213–8.
7. MoradzadehK,LarijaniB,KeshtkarA,Hossein-NezhadA, RajabianR,NabipourI,etal.Normativevaluesofvitamind amongiranianpopulation:apopulationbasedstudy.IntJ OsteoporosisMetabolicDis.2008;1(1):8–15.
8. WorldHealthOrganization.Assessmentoffractureriskand itsapplicationtoscreeningforpostmenopausalosteoporosis. TechnicalSupportSeries,No.843.Geneva:WHO;1994.
9. RahmanSA,CheeWS,YassinZ,ChanSP.VitaminDstatus amongpost-menopausalMalaysianwomen.AsiaPacJClin Nutr.2004;13(3):255–60.
10.RasoAA,NavarraSA,Li-YuJ,TorralbaTP.SurveyofvitaminD levelsamongpostmenopausalFilipinowomenwith
osteoporosis.IntJRheumDis.2009;12(3):225–9.
11.AryaV,BhambriR,GodboleMM,MithalA.VitaminDstatus anditsrelationshipwithbonemineraldensityinhealthy AsianIndians.OsteoporosInt.2004;15(1):56–61.
12.KhashayarP,AghaeiMeybodiHR,RezaiHomamiM,Amini MR,Mohajeri-TehraniMR,HeshmatR,etal.The
discriminativevalueofvariousbiochemicalparametersin detectingvaryingdegreesofvitaminDdeficiencyinthe Iranianpopulation.ClinLab.2011;57(3–4):163–70.
13.LipsP.VitaminDdeficiencyandsecondary
hyperparathyroidismintheelderly:consequencesforbone lossandfracturesandtherapeuticimplications.EndocrRev. 2001;22(4):477–501.
14.TsaiK,HsuS,ChengJ,YangR.VitaminDstoresofurban womeninTaipei:effectonbonedensityandboneturnover, andseasonalvariation.Bone(NY).1997;20(4):371–4.
15.FradingerE,ZanchettaJ.VitaminDandbonemineraldensity inambulatorywomenlivinginBuenosAires,Argentina. OsteoporosInt.2001;12(1):24–7.
16.LipsP,DuongT,OleksikA,BlackD,CummingsS,CoxD,etal. AglobalstudyofvitaminDstatusandparathyroidfunction inpostmenopausalwomenwithosteoporosis:baselinedata fromthemultipleoutcomesofraloxifeneevaluationclinical trial.JClinEndocrinolMetab.2001;86(3):1212–21.
17.Bischoff-FerrariH,DietrichT,OravE,Dawson-HughesB. Positiveassociationbetween25-hydroxyvitaminDlevelsand bonemineraldensity:apopulation-basedstudyofyounger andolderadults.AmJMed.2004;116(9):634–9.
18.ScharlaSH,Scheidt-NaveC,LeidigG,WoitgeH,WusterC, SeibelMJ,etal.Lowerserum25-hydroxyvitaminDis associatedwithincreasedboneresorptionmarkersandlower bonedensityattheproximalfemurinnormalfemales:a population-basedstudy.ExpClinEndocrinolDiabetes. 1996;104(3):289–92.
19.VillarealDT,CivitelliR,ChinesA,AvioliLV.Subclinicalvitamin Ddeficiencyinpostmenopausalwomenwithlowvertebral bonemass.JClinEndocrinolMetab.1991;72(3):628–34.
20.SahotaO,MasudT,SanP,HoskingD.VitaminDinsufficiency increasesboneturnovermarkersandenhancesbonelossat thehipinpatientswithestablishedvertebralosteoporosis. ClinEndocrinol(Oxf).1999;51(2):217–21.
21.HosseinpanahF,RambodM,Hossein-nejadA,LarijaniB,Azizi F.AssociationbetweenvitaminDandbonemineraldensity inIranianpostmenopausalwomen.JBoneMinerMetab. 2008;26(1):86–92.
22.SadatAliM,AlElgHA,AlTurkiHA,Al-MulhimFA,Al-AliAK. InfluenceofvitaminDlevelsonbonemineraldensityand osteoporosis.AnnSaudiMed.2011;31(6):602–8.
23.ChakiO,YoshikataI,KikuchiR,NakayamaM,UchiyamaY, HiraharaF,etal.Thepredictivevalueofbiochemicalmarkers ofboneturnoverforbonemineraldensityinpostmenopausal Japanesewomen.JBoneMinerRes.2000;15(8):1537–44.